Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2014

Open Access 01-12-2014 | Case report

Hungry bone syndrome and normalisation of renal phosphorus threshold after total parathyroidectomy for tertiary hyperparathyroidism in X-linked hypophosphataemia: a case report

Authors: Rachel K Crowley, Mark Kilbane, Thomas FJ King, Michelle Morrin, Myra O’Keane, Malachi J McKenna

Published in: Journal of Medical Case Reports | Issue 1/2014

Login to get access

Abstract

Introduction

This is the first report of which the authors are aware to describe this c.2166delinsGG mutation in X-linked hypophosphataemia and to describe normalisation of renal threshold for phosphate excretion after parathyroidectomy for tertiary hyperparathyroidism in X-linked hypophosphataemia.

Case presentation

We present the case of a 34-year-old Caucasian woman with X-linked hypophosphataemia. She developed tertiary hyperparathyroidism with markedly high bone turnover requiring total parathyroidectomy and had prolonged requirement for intravenous calcium infusion after surgery. She had a novel mutation in her phosphate-regulating gene with homologies to endopeptidases on the X-chromosome and had an unusual degree of dependence on phosphate supplementation. Prior to operative intervention she had a trial of cinacalcet that improved bone turnover markers when used in isolation but which led to a paradoxical rise in parathyroid hormone levels when given with phosphate supplementation. After correction of hungry bone syndrome, the renal phosphorus threshold normalised as a manifestation of hypoparathyroid state despite marked elevation in level of fibroblast growth factor 23.

Conclusions

This case illustrates the risk of tertiary hyperparathyroidism as a complication of treatment for hypophosphataemia; it highlights the morbidity associated with hungry bone syndrome and provides novel insight into renal handling of phosphorus.
Appendix
Available only for authorised users
Literature
1.
go back to reference Imel EA, Econs MJ: Approach to the hypophosphatemic patient. J Clin Endocrinol Metab. 2012, 3: 696-706.CrossRef Imel EA, Econs MJ: Approach to the hypophosphatemic patient. J Clin Endocrinol Metab. 2012, 3: 696-706.CrossRef
2.
go back to reference Carpenter TO, Imel EA, Holm IA, de Beur SM J, Insogna KL: A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res. 2011, 7: 1381-1388.CrossRef Carpenter TO, Imel EA, Holm IA, de Beur SM J, Insogna KL: A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res. 2011, 7: 1381-1388.CrossRef
3.
go back to reference Nanda KS, Ryan EJ, Murray BF, Brady JJ, McKenna MJ, Nolan N, O’Farrelly C, Hegarty JE: Effect of chronic hepatitis C virus infection on bone disease in postmenopausal women. Clin Gastroenterol Hepatol. 2009, 8: 894-899.CrossRef Nanda KS, Ryan EJ, Murray BF, Brady JJ, McKenna MJ, Nolan N, O’Farrelly C, Hegarty JE: Effect of chronic hepatitis C virus infection on bone disease in postmenopausal women. Clin Gastroenterol Hepatol. 2009, 8: 894-899.CrossRef
4.
go back to reference Francis F, Hennig S, Korn B, Reinhardt R, de Jong P, Poustka A, Lehrach H, Rowe PSN, Goulding JN, Summerfield T, Mountford R, Read AP, Popowska E, Pronicka E, Davies KE, O’Riordan JLH, Econs MJ, Nesbitt T, Drezner MK, Oudet C, Pannetier S, Hanauer A, Strom TM, Meindl A, Lorenz B, Cagnoli B, Mohnike KL, Murken J, Meitinger T: A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet. 1995, 2: 130-136.CrossRef Francis F, Hennig S, Korn B, Reinhardt R, de Jong P, Poustka A, Lehrach H, Rowe PSN, Goulding JN, Summerfield T, Mountford R, Read AP, Popowska E, Pronicka E, Davies KE, O’Riordan JLH, Econs MJ, Nesbitt T, Drezner MK, Oudet C, Pannetier S, Hanauer A, Strom TM, Meindl A, Lorenz B, Cagnoli B, Mohnike KL, Murken J, Meitinger T: A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet. 1995, 2: 130-136.CrossRef
5.
go back to reference Imel EA, Econs MJ: Fibroblast growth factor 23: roles in health and disease. J Am Soc Nephrol. 2005, 9: 2565-2575.CrossRef Imel EA, Econs MJ: Fibroblast growth factor 23: roles in health and disease. J Am Soc Nephrol. 2005, 9: 2565-2575.CrossRef
6.
go back to reference Hu MC, Shi M, Zhang J, Pastor J, Nakatani T, Lanske B, Razzaque MS, Rosenblatt KP, Baum MG, Kuro-o M, Moe OW: Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J. 9: 3438-3450. Hu MC, Shi M, Zhang J, Pastor J, Nakatani T, Lanske B, Razzaque MS, Rosenblatt KP, Baum MG, Kuro-o M, Moe OW: Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J. 9: 3438-3450.
7.
go back to reference Rivkees SA, el-Hajj-Fuleihan G, Brown EM, Crawford JD: Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. J Clin Endocrinol Metab. 1992, 6: 1514-1518. Rivkees SA, el-Hajj-Fuleihan G, Brown EM, Crawford JD: Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. J Clin Endocrinol Metab. 1992, 6: 1514-1518.
8.
go back to reference Savio RM, Gosnell JE, Posen S, Reeve TS, Delbridge LW: Parathyroidectomy for tertiary hyperparathyroidism associated with X-linked dominant hypophosphatemic rickets. Arch Surg. 2004, 2: 218-222.CrossRef Savio RM, Gosnell JE, Posen S, Reeve TS, Delbridge LW: Parathyroidectomy for tertiary hyperparathyroidism associated with X-linked dominant hypophosphatemic rickets. Arch Surg. 2004, 2: 218-222.CrossRef
9.
go back to reference Albright F, Butler AM, Bloomberg E: Rickets resistant to vitamin D therapy. Am J Dis Child. 1937, 54: 529-547. Albright F, Butler AM, Bloomberg E: Rickets resistant to vitamin D therapy. Am J Dis Child. 1937, 54: 529-547.
10.
go back to reference Harrison HE, Harrison HC, Lifshitz F, Johnson AD: Growth disturbance in hereditary hypophosphatemia. Am J Dis Child. 1966, 4: 290-297. Harrison HE, Harrison HC, Lifshitz F, Johnson AD: Growth disturbance in hereditary hypophosphatemia. Am J Dis Child. 1966, 4: 290-297.
11.
go back to reference Bai X, Miao D, Goltzman D, Karaplis AC: Early lethality in Hyp mice with targeted deletion of Pth gene. Endocrinology. 2007, 10: 4974-4983.CrossRef Bai X, Miao D, Goltzman D, Karaplis AC: Early lethality in Hyp mice with targeted deletion of Pth gene. Endocrinology. 2007, 10: 4974-4983.CrossRef
12.
go back to reference Alon US, Levy-Olomucki R, Moore WV, Stubbs J, Liu S, Quarles LD: Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clin J Am Soc Nephrol. 2008, 3: 658-664. 10.2215/CJN.04981107.CrossRefPubMedPubMedCentral Alon US, Levy-Olomucki R, Moore WV, Stubbs J, Liu S, Quarles LD: Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clin J Am Soc Nephrol. 2008, 3: 658-664. 10.2215/CJN.04981107.CrossRefPubMedPubMedCentral
13.
go back to reference Marks KH, Kilav R, Berman E, Naveh-Many T, Silver J: Parathyroid hormone gene expression in Hyp mice fed a low-phosphate diet. Nephrol Dial Transplant. 1997, 8: 1581-1585.CrossRef Marks KH, Kilav R, Berman E, Naveh-Many T, Silver J: Parathyroid hormone gene expression in Hyp mice fed a low-phosphate diet. Nephrol Dial Transplant. 1997, 8: 1581-1585.CrossRef
14.
go back to reference Perwad F, Azam N, Zhang MY, Yamashita T, Tenenhouse HS, Portale AA: Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology. 2005, 12: 5358-5364.CrossRef Perwad F, Azam N, Zhang MY, Yamashita T, Tenenhouse HS, Portale AA: Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology. 2005, 12: 5358-5364.CrossRef
15.
go back to reference Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M: Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med. 1991, 26: 1843-1848.CrossRef Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M: Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med. 1991, 26: 1843-1848.CrossRef
16.
go back to reference Yavropoulou MP, Kotsa K, Gotzamani Psarrakou A, Papazisi A, Tranga T, Ventis S, Yovos JG: Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review. Hormones (Athens). 2010, 3: 274-278.CrossRef Yavropoulou MP, Kotsa K, Gotzamani Psarrakou A, Papazisi A, Tranga T, Ventis S, Yovos JG: Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review. Hormones (Athens). 2010, 3: 274-278.CrossRef
Metadata
Title
Hungry bone syndrome and normalisation of renal phosphorus threshold after total parathyroidectomy for tertiary hyperparathyroidism in X-linked hypophosphataemia: a case report
Authors
Rachel K Crowley
Mark Kilbane
Thomas FJ King
Michelle Morrin
Myra O’Keane
Malachi J McKenna
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2014
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-8-84

Other articles of this Issue 1/2014

Journal of Medical Case Reports 1/2014 Go to the issue